NCT04106219 2026-04-21
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Eli Lilly and Company
Phase 1 Active not recruiting
Eli Lilly and Company
M.D. Anderson Cancer Center
Children's Cancer Hospital Egypt 57357
Beijing Children's Hospital
University of Rochester